What is CVE-2026-74794?
Scriban before 6.6.0 contains an infinite recursion vulnerability in object rendering when the ObjectRecursionLimit property defaults to unlimited. Attackers can supply circular reference objects to the template context, exhausting stack space and triggering an uncatchable StackOverflowException that terminates the hosting process.
The record classifies CVE-2026-74794 under weakness class CWE-674. Its CVSS v3 base vector states that the flaw is reachable remotely over the network, needs no prior authentication, needs no user interaction, and has high impact on availability. 1 affected-product entry is recorded, across 1 vendor, listed below. The identifier was first published 95 days ago.
Severity and exploitation probability
- CVSS v3.1 base score
- 7.5 — HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H - CVSS v4.0 base score
- 8.7
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N - EPSS (FIRST)
- 0.2% probability of exploitation in the next 30 days, higher than 20.3% of all scored CVEs
- CISA KEV
- Not listed in the CISA Known Exploited Vulnerabilities catalog
- Threadlinqs priority
- 4.6/10 — a Threadlinqs composite of the CVSS base score, the EPSS percentile and public exploit availability
- Published
- 2026-08-16
Is CVE-2026-74794 being exploited?
It currently carries a trending score of 35 in the Threadlinqs vulnerability feed.
Affected products and versions
- scriban: scriban
How to fix CVE-2026-74794
Vendor advisory: https://github.com/scriban/scriban/security/advisories/GHSA-grr9-747v-xvcp. Apply the vendor fix referenced above to every affected product listed in this record, then confirm the running version against the vendor advisory.
Threat activity tracking CVE-2026-74794
No threat campaign in the Threadlinqs corpus currently references CVE-2026-74794, in its CVE list or as an indicator. The linkage is recomputed from the live corpus on every daily ingest, so this section fills in as soon as a tracked campaign cites the identifier.
Sources
Enriched from CVE.org, FIRST EPSS.